# Application of Nanopore Adaptive Sequencing

> **NCT06542042** · — · NOT_YET_RECRUITING · sponsor: **Shenzhen Third People's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Liver Transplant Infection

## Interventions

- **DIAGNOSTIC_TEST:** NAS, NGS and Laboratory tests

## Key facts

- **NCT ID:** NCT06542042
- **Lead sponsor:** Shenzhen Third People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-10-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06542042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06542042, "Application of Nanopore Adaptive Sequencing". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06542042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
